Radevski, F., Peraic, P., Maek, T., Starevi, K., Krezic, I., Pavlov, K., Drmic, D., Kralj, T., Seiwerth, S., Sikiric, P., & Kokot, A
Combination therapy with ibrexafungerp (Formerly SCY-078), a first-in-class triterpenoid inhibitor of (13)--d-glucan synthesis, and isavuconazole for treatment of experimental invasive pulmonary aspergillosis
Sigma-1 receptors: a new pathway for the modulation of store-operated calcium entry
Instead of visiting a clinic, patients can receive professional treatment from licensed healthcare providers in the comfort of their homes
If you notice a decrease in its effectiveness, it may have degraded
However, these five species do encode alternative sequences that are mitochondrially localised, as PRX5 typically is